News

Nevan Krogan, PhD, is a mapmaker, but the object of his exploration is not any newfound continent or alien world. Instead, he and his colleagues map cells. Rather than cities, towns and interstates, these maps show proteins, genes, and the shifting, convoluted network of interactions between them

The National Institute on Minority Health and Health Disparities (NIMHD) has appointed Anna Maria Nápoles, PhD, MPH, as scientific director of its Division of Intramural Research. Nápoles, a UC San Francisco behavioral epidemiologist, is the first Latina to be named a scientific director at the

A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant “driver” mutation that can be treated in isolation with a single targeted drug. Instead, the new research finds one of the world’s most deadly forms of lung cancer is driven by changes in

Smartphones and emotional crises, social media and tanning beds are seemingly disconnected – but UC San Francisco researcher Eleni Linos, MD, DrPH, has started to make an impact on health by her focus on how technology can influence our behaviors. Watch Dreamforce Talk Eleni Linos, MD, DrPH, will be

One of UC San Francisco’s groundbreaking cancer programs will be prominently featured at the 2017 Dreamforce conference through an interactive exposition and a talk by two researchers. UCSF at Dreamforce “Tech and Health: Connection as Cure” (live stream) Monday, Nov. 6 9:30 a.m.-10 a.m. Featuring

Doctors have long recognized that children with Down syndrome are significantly more susceptible to leukemia, and have believed that they also were at higher risk of treatment-related chronic conditions. Now, new research led by UCSF Benioff Children’s Hospital San Francisco, with data from the

UC San Francisco researchers have discovered a gene vulnerability that could let oncologists wipe out drug-resistant cancers across many different cancer types. The findings, published in Nature on November 1, 2017, suggest a promising new approach to preventing cancer recurrence, if they can be